Breast Cancer Trial, Recruiting NCT05652569 Sponsor: German Cancer Research Center Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05652569
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a male or female breast cancer patient aged 18 or older, or your legal guardian has agreed to the consent form on your behalf
  • You have advanced or metastatic breast cancer (this applies regardless of the stage, subtype, or how many previous treatments you have had)
  • You are willing and able to sign the consent form agreeing to take part in the trial

Who may not be able to join:

  • You have early-stage breast cancer (rather than advanced or metastatic breast cancer)
  • A tissue sample (biopsy) cannot be taken from you, for example because of where the affected area is located in your body or due to your current health condition
  • You have a physical or mental condition, or a serious additional illness, that would make it difficult for you to participate fully in the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
German Cancer Research Center
Registry
ClinicalTrials.gov
Start date
12 June 2017
Est. completion
31 December 2030

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Setup of the molecular profiling diagnostic platform and feasibility of genomic profiling in metastatic breast cancer.; Total number of patients eligible for clinical trials and targeted therapies based on clinical characteristics and comprehensive tumor features.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov